NewsRoom Articles - Page 90 of 616

MondayJan 22, 2024 4:20 pm

420 with CNW — Feds Finally Publish Documents Revealing HHS Cannabis Rescheduling Recommendation

The federal government has released documents confirming that the U.S. Health and Human Services has recommended that the DEA categorize marijuana under Schedule III. Currently, the Controlled Substances Act classifies marijuana as a Schedule I substance, which means it has a high potential for abuse and has no accepted medical use. Health officials explained that marijuana had a lower potential for abuse in comparison to other substances under Schedule I or II and was already accepted for medical use in America. In their review, the health officials stated that more than 30,000 healthcare professionals across various jurisdictions in the U.S.…

MondayJan 22, 2024 4:20 am

420 with CNW — 2023 Data Shows Enrollment in Florida’s Medical Cannabis Program Kept Growing

A recent annual report has shown that the number of persons registered for the medical cannabis program in Florida experienced a gradual increase throughout the fiscal year 2023. However, the pace of growth showed a slight deceleration compared to earlier periods, attributed to the system’s maturation and increased focus on potential recreational cannabis legalization. According to the report, patient enrollment saw a 15% increase in the fiscal year 2022–2023 compared to 2021–2022. The concluded fiscal year witnessed a decrease in daily doses, primarily influenced by Florida’s emergency rule, which imposed limits on daily dosing. Additionally, the report highlighted a consistent…

FridayJan 19, 2024 4:20 pm

420 with CNW — Thailand Passes Draft Law Reversing Recreational Cannabis Legalization

Thailand’s recent political shift has set the stage for the introduction of fresh marijuana legislation, marking a major turnaround only 18 months after the nation took steps toward decriminalizing the substance. The initial lenient regulations sparked a flourishing marijuana industry, serving both locals and tourists across southeast Asia. However, the conservative coalition government, which assumed power late last year, has pledged to enforce stricter rules, restricting marijuana usage solely to medical purposes. Last week, the nation’s health ministry unveiled a draft measure outlining severe penalties, including high fines and potential one-year prison sentences for violators. The proposed legislation expressly limits…

FridayJan 19, 2024 4:20 am

420 with CNW — Data Shows Recreational Cannabis Sales Exhibited Mixed Results for Growth in 2023

Last year saw many regulated recreational cannabis markets record significant growth in their sales. While established markets such as Colorado recorded slight declines in sales, states such as Maine and Arizona saw growth in their markets. Below, we examine adult-use sales using data from regulators in different states. Arizona Recreational sales started strong last year, with monthly recreational cannabis sales peaking in March at $100 million. The state launched its adult-use cannabis market in 2021. Washington State Adult-use cannabis sales in the state have relaxed since the pandemic, with the state selling only $1.14 billion in recreational cannabis through November…

ThursdayJan 18, 2024 4:20 pm

420 with CNW — States with Legal Marijuana Markets See Higher College Applications

New data shows that states that have legalized recreational cannabis recorded a short-term boost in college applications from prospective students. The colleges also received more applications overall. The data was collected in a study, which had its findings recently published in the “Contemporary Economic Policy” journal. The researchers used the Integrated Postsecondary Education Data System to obtain data on various college metrics, including detailed tuition prices prior to and after financial aid applications, school application numbers and demographic characteristics of students. The study determined that applications for colleges in states the year that recreational cannabis was legalized increased by more…

ThursdayJan 18, 2024 4:20 am

420 with CNW — GOP Medical Cannabis Plan in Wisconsin Receives Muted Response

Wisconsin GOP assembly legislators have put forth a proposal aimed at legalizing medical cannabis in the state. The proposal, however, received a tepid response from Governor Tony Evers (D) and senate GOP leaders due to its highly restrictive nature. Unlike the broader legalization efforts advocated by Democrats and Gov. Evers through the years, the proposed bill focuses on allowing medical cannabis use only for severely ill individuals dealing with chronic diseases such as cancer, glaucoma, HIV/AIDS, chronic pain and nausea. However, the bill introduces certain restrictions, such as limiting distribution to only five state-operated locations and prohibiting the use of…

WednesdayJan 17, 2024 4:20 pm

420 with CNW — Study Says Marijuana Won’t Enhance Performance But Will Make Exercising More Fun

A new study has found that smoking marijuana prior to a workout can make exercise more enjoyable and boost a person’s motivation. The study, which involved 42 volunteer runners, released its findings almost a decade after Colorado became the first state in the United States to offer legal sales of recreational cannabis. The investigators took survey data and fitness measurements then assigned each volunteer a dispensary where they could pick a flower strain that contained mostly THC or CBD. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are two of the primary compounds found in marijuana. Unlike TH, CBD doesn’t induce any high.…

WednesdayJan 17, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Expedite Human and Animal Studies on DehydraTECH’s Effectiveness on GLP-1 Drugs Following Positive Results from Pilot Study

Lexaria, a global specialist in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 on the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of GLP-1 drug, semaglutide The results showed improved delivery of semaglutide to the bloodstream, with the drug showing approximately 44% higher levels than the control 24 hours after ingestion of a single dose DehydraTECH GLP-1 processed semaglutide also proved to be better tolerated than the control, with the latter resulting in some cases of moderate nausea and diarrhea This milestone brings Lexaria closer to tapping into the…

WednesdayJan 17, 2024 4:20 am

420 with CNW — Florida GOP Lawmaker Proposes Bill to Restrict THC potency If Voters Approve Recreational Marijuana

With the prospect of a potential November vote in Florida on cannabis legalization, a GOP legislator, Representative Ralph Massullo, has introduced a measure that would establish strict restrictions on THC potency in the event of voter approval. Introduced last week, Massullo’s measure suggests a THC cap significantly lower than the prevailing limits in most cannabis markets. The proposed limitations would become effective 30 days after voters endorse any future constitutional amendment endorsing legalization. The measure proposes a 10% THC limit for smoking-related marijuana products and a 60% limit for other cannabis products, such as extracts. The highest amount of THC…

TuesdayJan 16, 2024 4:20 pm

420 with CNW — UFC Officially Strikes Cannabis Off List of Banned Substances

During the last week of December, the Ultimate Fighting Championship (UFC) announced that was formally eliminating cannabis from its list of banned substances for athletes. The change in policy, which took effect on Dec. 31, 2023, also involves entering into a partnership with Drug Free Sport International, its sample collection and shipping company. The UFC also revealed that it was amending its list based on historical findings, despite stating that it was modelling its list of prohibited substances after the World Anti-Doping Agency. In 2021, the UFC adopted a policy change that protected professional fighters from penalizations over positive THC…

News and publishing service for cannabis related companies

Contact us: 512.354.7000